161 related articles for article (PubMed ID: 36450931)
1. Metabolic syndrome is associated with aggressive prostate cancer regardless of race.
Guerrios-Rivera L; Howard LE; Wiggins EK; Hoyo C; Grant DJ; Erickson TR; Ithisuphalap J; Freedland AR; Vidal AC; Fowke JH; Freedland SJ
Cancer Causes Control; 2023 Mar; 34(3):213-221. PubMed ID: 36450931
[TBL] [Abstract][Full Text] [Related]
2. The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort.
Gaines AR; Turner EL; Moorman PG; Freedland SJ; Keto CJ; McPhail ME; Grant DJ; Vidal AC; Hoyo C
Cancer Causes Control; 2014 Aug; 25(8):1029-35. PubMed ID: 24879044
[TBL] [Abstract][Full Text] [Related]
3. Dietary inflammatory index (DII) and risk of prostate cancer in a case-control study among Black and White US Veteran men.
Vidal AC; Oyekunle T; Howard LE; Shivappa N; De Hoedt A; Figueiredo JC; Taioli E; Fowke JH; Lin PH; Hebert JR; Freedland SJ
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):580-587. PubMed ID: 30980026
[TBL] [Abstract][Full Text] [Related]
4. Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study.
Jenkins KR; Oyekunle T; Howard LE; Wiggins EK; Freedland SJ; Allott EH
Cancer Causes Control; 2021 Apr; 32(4):337-346. PubMed ID: 33532986
[TBL] [Abstract][Full Text] [Related]
5. Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort.
Pereira V; Oyekunle T; Janes J; Amling CJ; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Klaassen Z; Freedland SJ; Vidal AC; Csizmadi I
Prostate; 2023 Aug; 83(11):1011-1019. PubMed ID: 37096737
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
7. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome increases the risk of aggressive prostate cancer detection.
Morote J; Ropero J; Planas J; Bastarós JM; Delgado G; Placer J; Celma A; de Torres IM; Carles J; Reventós J; Doll A
BJU Int; 2013 Jun; 111(7):1031-6. PubMed ID: 22883053
[TBL] [Abstract][Full Text] [Related]
9. Temporal and spatial trends and determinants of aggressive prostate cancer among Black and White men with prostate cancer.
Wang M; Chi G; Bodovski Y; Holder SL; Lengerich EJ; Wasserman E; McDonald AC
Cancer Causes Control; 2020 Jan; 31(1):63-71. PubMed ID: 31732913
[TBL] [Abstract][Full Text] [Related]
10. Obesity, race, and long-term prostate cancer outcomes.
Vidal AC; Oyekunle T; Howard LE; De Hoedt AM; Kane CJ; Terris MK; Cooperberg MR; Amling CL; Klaassen Z; Freedland SJ; Aronson WJ
Cancer; 2020 Aug; 126(16):3733-3741. PubMed ID: 32497282
[TBL] [Abstract][Full Text] [Related]
11. Association of the COVID-19 Pandemic With Rates of Prostate Cancer Biopsies and Diagnoses in Black vs White US Veterans.
Klaassen Z; Stock S; Waller J; De Hoedt A; Freedland SJ
JAMA Oncol; 2022 Jun; 8(6):914-918. PubMed ID: 35389461
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
[TBL] [Abstract][Full Text] [Related]
13. Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database.
Yirga A; Oyekunle T; Howard LE; De Hoedt AM; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Taioli E; Fowke JH; Klaanssen Z; Freedland SJ; Vidal AC
Cancer Causes Control; 2021 Feb; 32(2):189-197. PubMed ID: 33392907
[TBL] [Abstract][Full Text] [Related]
14. Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer.
Vidal AC; Duong F; Howard LE; Wiggins E; Freedland SJ; Bhowmick NA; Gong J
Anticancer Res; 2020 Mar; 40(3):1459-1462. PubMed ID: 32132043
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in circulating mitochondria-derived peptides may contribute to prostate cancer health disparities.
Ramirez-Torres A; Reagan AL; Howard LE; Wiggins E; Vidal AC; Wan J; Miller B; Freedland SJ; Cohen P
Prostate; 2022 Sep; 82(13):1248-1257. PubMed ID: 35789022
[TBL] [Abstract][Full Text] [Related]
16. Interplay between exercise and BMI; results from an equal access, racially diverse biopsy study.
Michael J; Oyekunle T; Howard L; De Hoedt A; Hoyo C; Grant D; Freedland S
Cancer Causes Control; 2019 Jan; 30(1):13-20. PubMed ID: 30523509
[TBL] [Abstract][Full Text] [Related]
17. Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
Jayachandran J; Bañez LL; Aronson WJ; Terris MK; Presti JC; Amling CL; Kane CJ; Freedland SJ;
Cancer; 2009 Nov; 115(22):5263-71. PubMed ID: 19670453
[TBL] [Abstract][Full Text] [Related]
18. Is Body Mass Index the Best Adiposity Measure for Prostate Cancer Risk? Results From a Veterans Affairs Biopsy Cohort.
Guerrios-Rivera L; Howard L; Frank J; De Hoedt A; Beverly D; Grant DJ; Hoyo C; Freedland SJ
Urology; 2017 Jul; 105():129-135. PubMed ID: 28408337
[TBL] [Abstract][Full Text] [Related]
19. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
20. Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study.
De Nunzio C; Albisinni S; Freedland SJ; Miano L; Cindolo L; Finazzi Agrò E; Autorino R; De Sio M; Schips L; Tubaro A
Urol Oncol; 2013 Oct; 31(7):997-1002. PubMed ID: 21925906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
